Our Story
Guangzhou Concord Cancer Center (GCCC) is a tertiary specialized oncology hospital owned and operated by Concord Medical Technology Development Group. Located in the International Medical and Health Demonstration Zone of Sun Yat-sen University within the Sino-Singapore Guangzhou Knowledge City, GCCC represents a new standard in cancer care in southern China.
Mission: To provide international-standard, patient-centered cancer care that is accessible, transparent, and coordinated — empowering patients from China and around the world in their fight against cancer.
Our Facilities
GCCC is designed and built to meet rigorous international standards. Our facility features:
- 400+ inpatient beds across specialized oncology wards
- State-of-the-art linear accelerators for precision radiation therapy
- Advanced diagnostic imaging including PET-CT, 3T MRI, and spectral CT
- Integrated operating theaters with minimally invasive and robotic-assisted surgical capabilities
- On-site pathology and molecular diagnostics laboratory
- International patient center with multilingual coordination services
- Comfortable inpatient rooms designed for extended stays with family accommodations
Clinical Philosophy
At GCCC, every cancer patient is treated through a multidisciplinary team (MDT) approach. This means that medical oncologists, radiation oncologists, surgical oncologists, pathologists, radiologists, and specialized nurses collaborate on each case to develop an individualized, evidence-based treatment plan.
We follow treatment protocols aligned with NCCN (National Comprehensive Cancer Network) and ESMO (European Society for Medical Oncology) guidelines, adapted for the specific needs of our diverse patient population.
Part of Concord Medical
Guangzhou Concord Cancer Center is part of Concord Medical Technology Development Group, one of China's leading oncology healthcare providers. Concord Medical operates a network of cancer centers and diagnostic imaging facilities across China, bringing decades of oncology expertise to every patient we serve.
This affiliation ensures that GCCC patients benefit from shared clinical expertise, continuous quality improvement programs, and access to the latest oncology research and treatment protocols.